Provenance du réseau au premier degré de Hisanori Maei
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Holding Company | Pharmaceuticals: Major | 29 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Hisanori Maei via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ACCELRYS, INC. | Packaged Software | Sales & Marketing | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Administrative Officer Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Administrative Officer | |
| INGRAM MICRO INC. | Information Technology Services | Director of Finance/CFO | |
| SEQUENOM, INC. | Medical Specialties | Public Communications Contact | |
| AETERNA ZENTARIS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Brunel University | College/University | Undergraduate Degree | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Manchester | College/University | Doctorate Degree | |
Hoechst Marion Roussel Ltd. (United Kingdom)
 Hoechst Marion Roussel Ltd. (United Kingdom) Pharmaceuticals: OtherHealth Technology Founded in 1994, Hoechst Marion Roussel Ltd. (United Kingdom) is a British pharmaceutical company that manufactures pharmaceutical products. Part of Sanofi, the company is based in Guildford, UK. | Pharmaceuticals: Other | Corporate Officer/Principal | |
The Royal Society of Chemistry
 The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Indiana University | College/University | Undergraduate Degree Masters Business Admin | |
| Pepperdine University | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Davis | College/University | Undergraduate Degree | |
| University of California, Irvine | College/University | Masters Business Admin | |
| University of Massachusetts | College/University | Doctorate Degree | |
Otsuka America, Inc.
 Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America, Inc. operates as a holding company for Otsuka America Pharmaceutical. Its primary objective is to bring products to the U.S. market developed by Otsuka America Pharmaceutical's Japanese parent company, Otsuka Pharmaceutical Co., Ltd. Those products center on treating neurological and cardiovascular diseases. The company was founded in 1989 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Staffordshire University | College/University | Undergraduate Degree | |
| The Open University | College/University | Masters Business Admin | |
| Ingram Micro North America | Director of Finance/CFO | ||
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Orange County United Way
 Orange County United Way Miscellaneous Commercial ServicesCommercial Services Orange County United Way engages in providing health, education, income and housing services. It specializes in mobilizing, fundraising, advocating, volunteering and financial stability. The company was founded in 1924 and is headquartered in Irvine, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chairman | |
| DERMIRA, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| SERES THERAPEUTICS, INC. | Biotechnology | General Counsel Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Graduate Degree | |
| JUNO THERAPEUTICS INC | Biotechnology | Founder | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Investor Relations Contact | |
| JW Biotechnology (Shanghai) Co. Ltd. | Director/Board Member | ||
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Corporate Officer/Principal Chief Executive Officer | |
| LONGEVERON INC. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Executive Officer Corporate Officer/Principal | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Executive Officer Corporate Officer/Principal | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Director/Board Member Chairman |
Statistiques
Internationale
| Etats-Unis | 41 |
| Royaume-Uni | 7 |
| Canada | 2 |
| Israël | 2 |
| Chine | 2 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Technology Services | 3 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 115 |
| Corporate Officer/Principal | 52 |
| Chairman | 38 |
| Independent Dir/Board Member | 38 |
| Chief Executive Officer | 30 |
Relations les plus connectées
| Insiders | |
|---|---|
| Mark Corrigan | 29 |
| Dennis Podlesak | 27 |
| Hans Bishop | 24 |
| Donald Hayden | 23 |
| David Mazzo | 23 |
| Keith Katkin | 16 |
| Thomas DesRosier | 15 |
| Robert McQuade | 14 |
| Joao Siffert | 14 |
| Craig Wheeler | 12 |
| Ian Clements | 11 |
| Rohan Palekar | 10 |
| Michael Cruse | 9 |
| Michael McFadden | 9 |
| Aziz Mottiwala | 8 |
- Bourse
- Insiders
- Hisanori Maei
- Connexions Sociétés
